10/7/25 08:56  | 10/3/25  | IMRX | Health | Drug | Pharmaceutical Preparations | Feinberg Peter | MA | D |  | P | 50 | 6.67 | 0 | 8 | 1 | 1,141 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/2/25 09:02  | 10/1/25  | IMRX | Health | Drug | Pharmaceutical Preparations | Morales Mallory | MA | O | Chief Ac | P | 2 | 6.39 | 0 | 0 | 1 | 28 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/2/25 08:57  | 10/1/25  | IMRX | Health | Drug | Pharmaceutical Preparations | Neufeld Leah R | MA | O | CHIEF PE | P | 5 | 6.38 | 0 | 1 | 4 | 23 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/2/25 08:52  | 10/1/25  | IMRX | Health | Drug | Pharmaceutical Preparations | Bookman Michael | MA | O | GC,SECRE | P | 7 | 6.83 | 0 | 1 | 26 | 5 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/1/25 08:59  | 9/30/25  | IMRX | Health | Drug | Pharmaceutical Preparations | Feinberg Peter | MA | D |  | P | 53 | 7.03 | 0 | 8 | 1 | 1,134 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/30/25 09:00  | 9/29/25  | IMRX | Health | Drug | Pharmaceutical Preparations | Feinberg Peter | MA | D |  | P | 36 | 7.18 | 0 | 5 | 0 | 1,126 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/7/25 08:59  | 7/2/25  | IMRX | Health | Drug | Pharmaceutical Preparations | Hausman Diana | MA | D |  | P | 20 | 3.61 | 0 | 6 | New | 6 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/7/25 08:52  | 7/2/25  | IMRX | Health | Drug | Pharmaceutical Preparations | Neufeld Leah R | MA | O | CHIEF PE | P | 2 | 3.57 | 0 | 1 | 7 | 11 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/3/25 09:12  | 7/1/25  | IMRX | Health | Drug | Pharmaceutical Preparations | Zeskind Benjamin J. | MA | DOT | P,CEO | P.m | 35 | 3.49 | 0 | 10 | 0 | 3,208 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/30/25 09:09  | 6/27/25  | IMRX | Health | Drug | Pharmaceutical Preparations | Schall Thomas J. | MA | D |  | P | 35 | 3.66 | 0 | 10 | 22 | 53 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/24/25 09:01  | 6/20/25  | IMRX | Health | Drug | Pharmaceutical Preparations | Hall Brett Matthew | MA | O | CHIEF SC | P.m | 35 | 2.58 | 0 | 13 | 4 | 359 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/24/25 08:52  | 6/20/25  | IMRX | Health | Drug | Pharmaceutical Preparations | Brakewood Harold Eugene | MA | O | Chief Bu | P | 5 | 2.53 | 0 | 2 | 49 | 6 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/23/25 09:09  | 6/18/25  | IMRX | Health | Drug | Pharmaceutical Preparations | Feinberg Peter | MA | D |  | P | 63 | 2.53 | 0 | 25 | 2 | 1,121 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/20/25 09:09  | 6/18/25  | IMRX | Health | Drug | Pharmaceutical Preparations | Zeskind Benjamin J. | MA | DOT | P,CEO | P | 50 | 2.39 | 0 | 21 | 1 | 3,198 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/18/25 09:11  | 6/17/25  | IMRX | Health | Drug | Pharmaceutical Preparations | Schall Thomas J. | MA | D |  | P | 89 | 2.21 | 0 | 40 | 999% | 43 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/25/24 16:03  | 3/22/24  | IMRX | Health | Drug | Pharmaceutical Preparations | Schall Thomas J. | MA | D |  | P | 7 | 2.55 | 0 | 3 | New | 3 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/25/24 09:13  | 3/22/24  | IMRX | Health | Drug | Pharmaceutical Preparations | Feinberg Peter | MA | D |  | P | 64 | 2.55 | 0 | 25 | 2 | 1,096 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/25/24 09:10  | 3/22/24  | IMRX | Health | Drug | Pharmaceutical Preparations | Brakewood Harold Eugene | MA | O | Chief Bu | P | 10 | 2.57 | 0 | 4 | New | 4 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/25/24 09:04  | 3/21/24  | IMRX | Health | Drug | Pharmaceutical Preparations | Morales Mallory | MA | O | Chief Ac | P.m | 4 | 2.67 | 0 | 2 | 22 | 8 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/21/24 09:11  | 3/20/24  | IMRX | Health | Drug | Pharmaceutical Preparations | Neufeld Leah R | MA | O | CHIEF PE | P | 11 | 2.88 | 0 | 4 | 61 | 10 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/21/24 09:06  | 3/20/24  | IMRX | Health | Drug | Pharmaceutical Preparations | Hall Brett Matthew | MA | O | CHIEF SC | P | 20 | 2.86 | 0 | 7 | 2 | 346 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/19/24 19:10  | 3/18/24  | IMRX | Health | Drug | Pharmaceutical Preparations | Berman Ann E | MA | D |  | P | 123 | 2.13 | 0 | 58 | 610 | 67 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/19/24 19:04  | 3/18/24  | IMRX | Health | Drug | Pharmaceutical Preparations | Feinberg Peter | MA | D |  | P.m | 183 | 2.44 | 0 | 75 | 8 | 1,071 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/19/24 18:59  | 3/19/24  | IMRX | Health | Drug | Pharmaceutical Preparations | Zeskind Benjamin J. | MA | DOT | P,CEO | P | 55 | 2.77 | 0 | 20 | 1 | 3,177 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/27/22 16:09  | 5/25/22  | IMRX | Health | Drug | Pharmaceutical Preparations | Hall Brett Matthew | MA | O | CHIEF SC | P | 10 | 3.92 | 0 | 3 | 1 | 333 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/18/22 19:28  | 5/17/22  | IMRX | Health | Drug | Pharmaceutical Preparations | Bookman Michael | MA | O | GC,SECRE | P | 5 | 4.88 | 0 | 1 | 71 | 2 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/17/22 17:15  | 5/16/22  | IMRX | Health | Drug | Pharmaceutical Preparations | Keating Laurie | MA | D |  | P | 35 | 5.00 | 0 | 7 | 100 | 14 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/12/22 17:37  | 5/12/22  | IMRX | Health | Drug | Pharmaceutical Preparations | Amin Biren | MA | O | CFO,TREA | P | 4 | 4.42 | 0 | 1 | 14 | 8 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/24/22 16:39  | 3/23/22  | IMRX | Health | Drug | Pharmaceutical Preparations | Zeskind Benjamin J. | MA | DOT | P,CEO | P | 24 | 8.02 | 0 | 3 | 0 | 3,152 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/23/22 18:38  | 3/23/22  | IMRX | Health | Drug | Pharmaceutical Preparations | Hall Brett Matthew | MA | O | CHIEF SC | P | 8 | 7.91 | 0 | 1 | 0 | 330 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/22/22 18:49  | 3/22/22  | IMRX | Health | Drug | Pharmaceutical Preparations | Barrett Scott | MA | O | CHIEF ME | P | 7 | 7.49 | 0 | 1 | 14 | 8 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/16/22 17:30  | 3/15/22  | IMRX | Health | Drug | Pharmaceutical Preparations | Feinberg Peter | MA | D |  | P | 45 | 6.75 | 0 | 7 | 1 | 996 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/15/22 17:53  | 3/15/22  | IMRX | Health | Drug | Pharmaceutical Preparations | Berman Ann E | MA | D |  | P | 38 | 6.40 | 0 | 6 | 171 | 10 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/21/21 17:53  | 9/20/21  | IMRX | Health | Drug | Pharmaceutical Preparations | Feinberg Peter | MA | D |  | P | 116 | 24.45 | 0 | 5 | 0 | 989 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/15/21 17:58  | 9/13/21  | IMRX | Health | Drug | Pharmaceutical Preparations | Feinberg Peter | MA | D |  | P | 131 | 21.50 | 0 | 6 | 1 | 985 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/14/21 16:47  | 9/13/21  | IMRX | Health | Drug | Pharmaceutical Preparations | Zeskind Benjamin J. | MA | DOT | P,CEO | P | 48 | 22.87 | 0 | 2 | 0 | 3,147 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/5/21 16:01  | 8/3/21  | IMRX | Health | Drug | Pharmaceutical Preparations | Cormorant Asset Management, LP | MA | H | Former 1 | P.d | 8,250 | 15.00 | 0 | 550 | 32 | 2,253 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/4/21 06:06  | 8/3/21  | IMRX | Health | Drug | Pharmaceutical Preparations | Feinberg Peter | MA | D |  | P.d | 4,375 | 15.00 | 0 | 292 |  | 115 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/4/21 06:06  | 8/3/21  | IMRX | Health | Drug | Pharmaceutical Preparations | Zeskind Benjamin J. | MA | DOT | P,CEO | P.d | 31 | 15.00 | 0 | 2 | 0 | 3,145 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/4/21 06:06  | 8/3/21  | IMRX | Health | Drug | Pharmaceutical Preparations | Keating Laurie | MA | D |  | P | 105 | 15.00 | 0 | 7 | New | 7 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/4/21 06:05  | 8/3/21  | IMRX | Health | Drug | Pharmaceutical Preparations | Hall Brett Matthew | MA | O | Chief Sc | P.d | 20 | 15.00 | 0 | 1 | 27 | 6 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/4/21 06:05  | 8/3/21  | IMRX | Health | BioPrd | Biological Products, (No Diag | Carpenter Robert J | MA | D |  | P.d | 4,875 | 15.00 | 0 | 325 | 39 | 1,149 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/4/21 06:05  | 8/3/21  | IMRX | Health | Drug | Pharmaceutical Preparations | Bookman Michael | MA | O | GC,Secre | P | 21 | 15.00 | 0 | 1 | New | 1 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/4/21 06:04  | 8/3/21  | IMRX | Health | Drug | Pharmaceutical Preparations | Berman Ann E | MA | D |  | P | 53 | 15.00 | 0 | 4 | New | 4 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/4/21 06:04  | 8/3/21  | IMRX | Health | Drug | Pharmaceutical Preparations | Barrett Scott | MA | O | Chief Me | P.d | 10 | 15.00 | 0 | 1 | 11 | 7 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/4/21 06:04  | 8/3/21  | IMRX | Health | Drug | Pharmaceutical Preparations | Amin Biren | MA | O | CFO,Trea | P.d | 63 | 15.00 | 0 | 4 | 153 | 7 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  |